M. Morimoto

发表

Antitumor Activity and Pharmacodynamic Biomarkers of a Novel and Orally Available Small-Molecule Antagonist of Inhibitor of Apoptosis Proteins

M. Yabuki, Sei Yoshida, T. Ishikawa, 2012, Molecular Cancer Therapeutics.

Amelioration of sexual behavior and motor activity deficits in a castrated rodent model with a selective androgen receptor modulator SARM-2f

M. Yamaoka, T. Hara, H. Fujita, 2017, PloS one.

Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part II: Optimization of 4-(pyrrolidin-1-yl)benzonitrile derivatives.

T. Hitaka, Masaharu Nakayama, J. Yano, 2017, Bioorganic & medicinal chemistry letters.

Prevention of body weight loss and sarcopenia by a novel selective androgen receptor modulator in cancer cachexia models.

Katsuji Aikawa, M. Yamaoka, T. Hara, 2017, Oncology letters.

A selective androgen receptor modulator SARM‐2f activates androgen receptor, increases lean body mass, and suppresses blood lipid levels in cynomolgus monkeys

M. Yamaoka, T. Hara, M. Morimoto, 2020, Pharmacology research & perspectives.

A Novel LSD1 Inhibitor T-3775440 Disrupts GFI1B-Containing Complex Leading to Transdifferentiation and Impaired Growth of AML Cells

R. Hara, M. Yabuki, Naoki Tomita, 2016, Molecular Cancer Therapeutics.

Fibroblast migratory factor derived from mouse colon carcinoma cells: Potential roles of fibronectin in tumor stroma formation

T. Irimura, M. Morimoto, 2001, Journal of cellular biochemistry.

Correction: Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication

K. Toyoshima, H. Miyashita, A. Hayashi, 2017, Oncogenesis.

Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication

K. Toyoshima, H. Miyashita, A. Hayashi, 2017, Oncogenesis.

Brain Testosterone Deficiency Leads to Down-Regulation of Mitochondrial Gene Expression in Rat Hippocampus Accompanied by a Decline in Peroxisome Proliferator-Activated Receptor-γ Coactivator 1α Expression

T. Horiguchi, T. Masaki, M. Morimoto, 2013, Journal of Molecular Neuroscience.

Intratumor Heterogeneity in Primary Kidney Cancer Revealed by Metabolic Profiling of Multiple Spatially Separated Samples within Tumors

K. Nutahara, T. Okegawa, A. Ando, 2017, EBioMedicine.

Orphan nuclear receptor HNF4G promotes bladder cancer growth and invasion through the regulation of the hyaluronan synthase 2 gene

T. Hara, T. Okegawa, T. Okegawa, 2013, Oncogenesis.

An inhibitor of apoptosis protein antagonist T-3256336 potentiates the antitumor efficacy of the Nedd8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924).

Peter G. Smith, M. Yabuki, Sei Yoshida, 2016, Biochemical and biophysical research communications.

Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.

T. Ochi, K. Aozasa, M. Greene, 1995, Oncogene.

Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs) Part III: Discovery of 4-(5-oxopyrrolidine-1-yl)benzonitrile derivative 2f as a clinical candidate.

Masaharu Nakayama, J. Yano, N. Habuka, 2017, Bioorganic & medicinal chemistry.

Prolyl-tRNA synthetase inhibition promotes cell death in SK-MEL-2 cells through GCN2-ATF4 pathway activation.

T. Arita, H. Miyashita, T. Hara, 2017, Biochemical and biophysical research communications.

Brain Testosterone Deficiency Leads to Down-Regulation of Mitochondrial Gene Expression in Rat Hippocampus Accompanied by a Decline in Peroxisome Proliferator-Activated Receptor-γ Coactivator 1α Expression

T. Horiguchi, T. Masaki, M. Morimoto, 2014, Journal of Molecular Neuroscience.

Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor

T. Miyazaki, J. Soeda, T. Hara, 2020, Biochemistry and biophysics reports.